Ultraslow SWL Versus Slow SWL for Ureteric Stones With High Attenuation Value

Ureteric Stone Clinical Trial

— ESWL  

Official title:

Ultraslow Full-power SWL Versus Slow SWL in Stones With High Attenuation Value

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03795545
• Other study ID #: 16231
• Status: Completed
• Phase: N/A
• Start date: January 11, 2019
• Est. completion date: August 12, 2019

Study information

• Verified date: December 2019
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Ultraslow full-power SWL versus slow power-ramping SWL in ureteric stones with high attenuation value

Description:

To evaluate the efficacy of ultraslow rate of SWL versus slow rate, power ramping SWL

Recruitment information / eligibility

• Status: Completed
• Enrollment: 101
• Est. completion date: August 12, 2019
• Est. primary completion date: July 16, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• single upper ureteric stone less than or equal to 2 cm

• radio-opaque stone

• high attenuation value (= 1000 HU) stone

Exclusion Criteria:

• Abnormal renal anatomy

• renal insufficiency

• solitary kidney

• coagulopathies

• uncontrolled hypertension

• renal artery or aortic aneurysm

• active urinary tract infection

• pregnancy

• severe skeletal malformations (spinal deformity) precluding proper stone localization

Related Conditions & MeSH terms

• Calculi
• Ureteral Calculi
• Ureteric Stone
• Ureterolithiasis

Intervention

Procedure:
• SWL
Shock wave lithotripsy

Locations

Country	Name	City	State
Egypt	Beni-Suef Hospitals	Bani Suwayf	Outside U.S./Canada

Sponsors (2)

Lead Sponsor	Collaborator
Cairo University	Beni-Suef University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	stone free rate	Complete clearance of stones in addition to clinically insignificant residual fragments	3 months following last session of SWL
Secondary	Complications rate	Comparison of rate of complications in both groups	3 months following last session of SWL